Ractigen Therapeutics
Pioneering RNAa therapeutics to treat undruggable diseases with innovative gene activation technology. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€109—164m (Dealroom.co estimates Jan 2022.)
Nantong Jiangsu (HQ)
Authorizing premium user...